Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
Mangarule, S, Palkar, S, Mitra, M, Ravi, MD, Singh, R, Moureau, A, Jayanth, MV, Patel, DM, Ravinuthala, S, Patnaik, BN, Jordanov, E, Noriega, F
Published in Vaccine: X (01.08.2022)
Published in Vaccine: X (01.08.2022)
Get full text
Journal Article
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India
Mangarule, S., Palkar, S., Mitra, M., Ravi, M.D., Dubey, A.P., Moureau, A., Jayanth, M.V., Patel, D.M., Ravinuthala, S., Jagga, S.R., Patnaik, B.N., Jordanov, E., Noriega, F.
Published in Vaccine: X (01.04.2022)
Published in Vaccine: X (01.04.2022)
Get full text
Journal Article
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study
Mangarule, S, Prashanth, S, Kawade, A, Ravi, MD, Padmavathi, IV, Palkar, S, Tripathi, VN, Singh, R, Maurya, M, Mitra, M, Shetty, RS, Kompithra, RZ, Dhaded, SM, Epari, V, Moureau, A, Jayanth, MV, Varghese, K, Ravinuthala, S, Kukian, D, Patnaik, BN, Noriega, F
Published in Vaccine: X (01.12.2022)
Published in Vaccine: X (01.12.2022)
Get full text
Journal Article